BostankoluG, AyhanY, CuhadarogluF, et al.Serotonin syndrome with a combination of aripiprazole and fluoxetine: A case report. Ther Adv Psychopharmacol, 2015; 5(2):138–140; doi: 10.1177/2045125314561467
2.
ChowLY, ChungD, LeungV, et al.Suicide attempt due to metoclopramide-induced akathisia. Int J Clin Pract, 1997; 51(5):330–331.
3.
CirayRO, TuncturkM. Effective treatment of 2 childhood depression cases carrying high risk of bipolar disorder with aripiprazole monotherapy. J Clin Psychopharmacol, 2021; 41(2):223–225; doi: 10.1097/JCP.0000000000001340
4.
CorrellCU, KohegyiE, ZhaoC, et al.Oral aripiprazole as maintenance treatment in adolescent schizophrenia: Results from a 52-week, randomized, placebo-controlled withdrawal study. J Am Acad Child Adolesc Psychiatry, 2017; 56(9):784–792; doi: 10.1016/j.jaac.2017.06.013
5.
DoeyT. Aripiprazole in pediatric psychosis and bipolar disorder: A clinical review. J Affect Disord, 2012; 138(Suppl.):S15–S21; doi: 10.1016/j.jad.2012.02.031
6.
DrakeRE, EhrlichJ. Suicide attempts associated with akathisia. Am J Psychiatry, 1985; 142(4):499–501; doi: 10.1176/ajp.142.4.499
7.
GreydanusDE, CallesJJr. Suicide in children and adolescents. Prim Care, 2007; 34(2):259–273; abstract vi; doi: 10.1016/j.pop.2007.04.013
8.
HellersteinDJ, BatchelderS, HylerS, et al.Aripiprazole as an adjunctive treatment for refractory unipolar depression. Prog Neuropsychopharmacol Biol Psychiatry, 2008; 32(3):744–750; doi: 10.1016/j.pnpbp.2007.11.024
9.
KirinoE. Efficacy and safety of aripiprazole in child and adolescent patients. Eur Child Adolesc Psychiatry, 2012; 21(7):361–368; doi: 10.1007/s00787-012-0270-0
10.
KomossaK, Rummel-KlugeC, SchmidF, et al.Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev, 2009;(4):CD006569; doi: 10.1002/14651858.CD006569.pub3
11.
LucireY, CrottyC. Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family. Pharmgenomics Pers Med, 2011; 4:65–81; doi: 10.2147/PGPM.S17445
12.
MartinSE, LiuRT, MernickLR, et al.Suicidal thoughts and behaviors in psychiatrically referred young children. Psychiatry Res, 2016; 246:308–313; doi: 10.1016/j.psychres.2016.09.038
13.
MontastrucF, NieR, LooS, et al.Association of aripiprazole with the risk for psychiatric hospitalization, self-harm, or suicide. JAMA Psychiatry, 2019; 76(4):409–417; doi: 10.1001/jamapsychiatry.2018.4149
14.
PaeCU, ForbesA, PatkarAA. Aripiprazole as adjunctive therapy for patients with major depressive disorder: Overview and implications of clinical trial data. CNS Drugs, 2011; 25(2):109–127; doi: 10.2165/11538980-000000000-00000
15.
ScholtenMR, SeltenJP. [Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug]. Ned Tijdschr Geneeskd, 2005; 149(41):2296–2298; https://www.ncbi.nlm.nih.gov/pubmed/16240856 (Suicidale ideaties en suicidepogingen na instelling op aripiprazol, een nieuw antipsychoticum.)
16.
ShapiroDA, RenockS, ArringtonE, et al.Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology, 2003; 28(8):1400–1411; doi: 10.1038/sj.npp.1300203
17.
ShearMK, FrancesA, WeidenP. Suicide associated with akathisia and depot fluphenazine treatment. J Clin Psychopharmacol, 1983; 3(4):235–236; doi: 10.1097/00004714-198308000-00006
18.
SheltonRC, TollefsonGD, TohenM,. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry, 2001; 158(1):131–134; doi: 10.1176/appi.ajp.158.1.131
19.
SoutulloC, Figueroa-QuintanaA. When do you prescribe antidepressants to depressed children?. Curr Psychiatry Rep, 2013; 15(7):366; doi: 10.1007/s11920-013-0366-3
20.
SpielmansGI, BermanMI, LinardatosE, et al.Adjunctive atypical antipsychotic treatment for major depressive disorder: A meta-analysis of depression, quality of life, and safety outcomes. PLoS Med, 2013; 10(3):e1001403; doi: 10.1371/journal.pmed.1001403
21.
StubbsJH, HutchinsDA, MountjoyCQ. Relationship of akathisia to aggressive and self-injurious behaviour: A prevalence study in a UK tertiary referral centre. Int J Psychiatry Clin Pract, 2000; 4(4):319–325; doi: 10.1080/13651500050517894
22.
SunCF, MansuriZ, TrivediC, et al.Homicidal ideation and psychiatric comorbidities in the inpatient adolescents aged 12–17. Front Psychiatry, 2022; 13:933524; doi: 10.3389/fpsyt.2022.933524
23.
ThomasJE, CaballeroJ, HarringtonCA. The incidence of akathisia in the treatment of schizophrenia with aripiprazole, asenapine and lurasidone: A meta-analysis. Curr Neuropharmacol, 2015; 13(5):681–691; doi: 10.2174/1570159x13666150115220221
24.
VaughnMG, CarboneJ, DeLisiM, et al.Homicidal ideation among children and adolescents: Evidence from the 2012–2016 Nationwide Emergency Department sample. J Pediatr, 2020; 219:216–222; doi: 10.1016/j.jpeds.2019.12.045
25.
ZhangJY, KowalDM, NawoschikSP, et al.Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms. Biochem Pharmacol, 2006; 71(4):521–529; doi: 10.1016/j.bcp.2005.11.007
